Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene
Burdon, Kathryn P., Fogarty, Rhys D., Shen, Weiyong, Abhary, Sotoodeh, Kaidonis, Georgia, Appukuttan, Binoy, Hewitt, Alex W., Sharma, Shiwani, Daniell, Mark, Essex, Rohan W., Chang, John H., Klebe, Sonja, Lake, Stewart R., Pal, Bishwanath, Jenkins, Alicia, Govindarjan, Gowthaman, Sundaresan, Periasamy, Lamoureux, Ecosse L., Ramasamy, Kim, Pefkianaki, Maria, Hykin, Philip G., Petrovsky, Nikolai, Brown, Matthew A., Gillies, Mark C., & Craig, Jamie E. (2015) Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene. Diabetologia, 58(10), pp. 2288-2297.
Diabetic retinopathy is a serious complication of diabetes mellitus and can lead to blindness. A genetic component, in addition to traditional risk factors, has been well described although strong genetic factors have not yet been identified. Here, we aimed to identify novel genetic risk factors for sight-threatening diabetic retinopathy using a genome-wide association study.
Retinopathy was assessed in white Australians with type 2 diabetes mellitus. Genome-wide association analysis was conducted for comparison of cases of sight-threatening diabetic retinopathy (n = 336) with diabetic controls with no retinopathy (n = 508). Top ranking single nucleotide polymorphisms were typed in a type 2 diabetes replication cohort, a type 1 diabetes cohort and an Indian type 2 cohort. A mouse model of proliferative retinopathy was used to assess differential expression of the nearby candidate gene GRB2 by immunohistochemistry and quantitative western blot.
The top ranked variant was rs3805931 with p = 2.66 × 10−7, but no association was found in the replication cohort. Only rs9896052 (p = 6.55 × 10−5) was associated with sight-threatening diabetic retinopathy in both the type 2 (p = 0.035) and the type 1 (p = 0.041) replication cohorts, as well as in the Indian cohort (p = 0.016). The study-wide meta-analysis reached genome-wide significance (p = 4.15 × 10−8). The GRB2 gene is located downstream of this variant and a mouse model of retinopathy showed increased GRB2 expression in the retina.
Genetic variation near GRB2 on chromosome 17q25.1 is associated with sight-threatening diabetic retinopathy. Several genes in this region are promising candidates and in particular GRB2 is upregulated during retinal stress and neovascularisation.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Blinding retinopathy, Diabetic complications, Genetic risk factors, Genome-wide association study, Müller cell, Proliferative retinopathy|
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2015 Springer-Verlag Berlin Heidelberg|
|Deposited On:||14 Oct 2015 22:43|
|Last Modified:||16 Feb 2016 02:59|
Repository Staff Only: item control page